Back
Insight Molecular Diagnostics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
IMDX
Insight Molecular Diagnostics, Inc.
Last Price:
$5.35
Seasonality Move:
20.46%
7 Day Trial
ALL ACCESS PASS
$
7
Insight Molecular Diagnostics, Inc. Stock Forecast
-
Over the next 52 weeks, Insight Molecular Diagnostics, Inc. has on average historically fallen by 11.3% based on the past 9 years of stock performance.
-
Insight Molecular Diagnostics, Inc. has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Insight Molecular Diagnostics, Inc. Stock Undervalued?The current Insight Molecular Diagnostics, Inc. [IMDX] share price is $5.41. The Score for IMDX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
IMDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Insight Molecular Diagnostics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Insight Molecular Diagnostics, Inc. has on average historically fallen by 11.3% based on the past 9 years of stock performance.
Insight Molecular Diagnostics, Inc. Stock Rating
Sell
50
Insight Molecular Diagnostics, Inc. (IMDX)
is a Sell
Is Insight Molecular Diagnostics, Inc. overpriced?
-
Insight Molecular Diagnostics, Inc. has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Insight Molecular Diagnostics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oncocyte.com
52-Week Data
52-Week High:
8.51
52-Week Low:
1.92
Prediction Charts
Market Cap:
155.1M
Price in USD:
5.41
Volume:
118.5K
Beta:
1.76
Technical Analysis
SMA50:
5.85
SMA100:
4.37
SMA200:
3.72
52-Wk Change:
144.8%
Stock Predictions
-
Is Insight Molecular Diagnostics, Inc. stock public?Yes, Insight Molecular Diagnostics, Inc. is a publicly traded company.
-
What is the Insight Molecular Diagnostics, Inc. stock quote today?The Insight Molecular Diagnostics, Inc. stock price is 5.41 USD today.
-
How to buy Insight Molecular Diagnostics, Inc. stock online?You can buy Insight Molecular Diagnostics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 5.76 | 5.52 | 5.84 | 5.44 |
| Dec-3 | 5.56 | 5.34 | 5.56 | 5.20 |
| Dec-4 | 5.27 | 5.58 | 5.69 | 5.27 |
| Dec-5 | 5.58 | 5.24 | 5.63 | 5.21 |
| Dec-8 | 5.23 | 4.94 | 5.25 | 4.92 |
| Dec-9 | 4.91 | 5.15 | 5.25 | 4.91 |
| Dec-10 | 5.12 | 5.09 | 5.25 | 5.09 |
| Dec-11 | 5.07 | 5.20 | 5.24 | 5.05 |
| Dec-12 | 5.16 | 5.22 | 5.25 | 5.07 |
| Dec-15 | 5.19 | 5.02 | 5.21 | 5.02 |
| Dec-16 | 4.98 | 5.10 | 5.10 | 4.98 |
| Dec-17 | 5.08 | 4.76 | 5.10 | 4.75 |
| Dec-18 | 4.94 | 5.19 | 5.34 | 4.92 |
| Dec-19 | 5.18 | 5.41 | 5.41 | 5.00 |
Insight Molecular Diagnostics, Inc. Earnings
Insight Molecular Diagnostics, Inc. Earnings Report: Per Share Insight Molecular Diagnostics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Insight Molecular Diagnostics, Inc. Forecast Revenue Growth
Insight Molecular Diagnostics, Inc. Stock Analysis: Historical quarterly revenues per share for Insight Molecular Diagnostics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.14 per share.
* Insight Molecular Diagnostics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.